biospectrumasiaApril 13, 2018
Tag: Boston Therapeutics , MTA
Boston Therapeutics inks a non-binding letter of intent with Medical Technology Associates to acquire MTA, a privately-held company dedicated to the development of novel biopharmaceuticals through its proprietary ALTAPURE technology. ALTAPURE technology is a proprietary process for purification and stabilization applied to purify biological extractions, e.g. blood products (animal), pituitary gland, pancreas and botanicals, specialty proteins, creating molecules of enhanced purity (quality) for biopharmaceutical development and volume for commercialization (quantity in kilograms).
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: